(Q45182687)

English

Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial

scientific article published on 9 December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

author name string

Klinkert ER

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Broekmans FJ

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Looman CW

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Habbema JD

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

te Velde ER

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

language of work or name

0 references

publication date

9 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Human Reproduction

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

611-615

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

The outcome of IVF-embryo transfer treatment in patients who develop three follicles or less.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Use of the antral follicle count to predict the outcome of assisted reproductive technologies.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Young low responders protected from untoward effects of reduced ovarian response.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Antral follicle counting in predicting the retrieved oocyte number after ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Increasing the gonadotrophin dose in the course of an in vitro fertilization cycle does not rectify an initial poor response

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Superovulation with a high gonadotropin dose for in vitro fertilization: is it effective?

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

In-vitro fertilization and embryo transfer in women aged 40 years and over

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH?

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Gonadotropin stimulation following GnRH-a priming for poor responders in in vitro fertilization-embryo transfer programs.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Outcome of assisted reproductive technology in women over the age of 41.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Clinical management of low ovarian response to stimulation for IVF: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Factors that affect outcome of in-vitro fertilisation treatment.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH663

21 January 2018

Identifiers

10.1093/HUMREP/DEH663

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45182687&oldid=2069350283"